NASDAQ:VACH Voyager Acquisition (VACH) Stock Price, News & Analysis $10.31 -0.01 (-0.10%) As of 05/27/2025 09:38 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About Voyager Acquisition Stock (NASDAQ:VACH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Voyager Acquisition alerts:Sign Up Key Stats Today's Range$10.31▼$10.3150-Day Range$10.17▼$10.3252-Week Range$9.95▼$11.20Volume105 shsAverage Volume126,033 shsMarket Capitalization$326.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewVoyager Acquisition Corp. is a blank check company. It formed for the purpose of merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Voyager Acquisition Corp. is based in BROOKLYN, N.Y.Read More… Receive VACH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Voyager Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address VACH Stock News HeadlinesVERAXA Biotech Appoints Rick Austin as Chief Scientific OfficerMay 20, 2025 | globenewswire.comVoyager Acquisition Corp.: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 6, 2025 | finanznachrichten.deAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.May 28, 2025 | Paradigm Press (Ad)VERAXA Biotech GmbH: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramMay 5, 2025 | finanznachrichten.deVeraxa to go public in $1.6bn SPAC deal with VoyagerApril 23, 2025 | msn.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comVERAXA Biotech and Voyager Acquisition Corp. ...April 23, 2025 | gurufocus.comVeraxa Biotech to merge with SPAC Voyager in $1.64 billion dealApril 23, 2025 | msn.comSee More Headlines VACH Stock Analysis - Frequently Asked Questions How have VACH shares performed this year? Voyager Acquisition's stock was trading at $10.02 at the start of the year. Since then, VACH stock has increased by 2.9% and is now trading at $10.31. View the best growth stocks for 2025 here. Who are Voyager Acquisition's major shareholders? Top institutional shareholders of Voyager Acquisition include AQR Arbitrage LLC (4.49%), Wolverine Asset Management LLC (4.46%), Westchester Capital Management LLC (3.99%) and Schechter Investment Advisors LLC (2.18%). How do I buy shares of Voyager Acquisition? Shares of VACH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/27/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinancial Services Industry Holding & other investment offices Sub-IndustryTrading Current SymbolNASDAQ:VACH CIK2006815 WebN/A Phone347-720-2907FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares31,625,000Free FloatN/AMarket Cap$326.05 million OptionableN/A BetaN/A The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:VACH) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
